Table 2. Main characteristics of reported cases of tick-borne encephalitis, European Union and European Economic Area countries, 2012−2016 (n = 12,500).
| Characteristics | Number of cases | Percent | Notification rate per 100,000 persons |
|---|---|---|---|
| Total | 12,500 | 100 | 0.54 |
| Age group (years) | |||
| < 20 | 1,402 | 11.2 | 0.29 |
| 20–29 | 1,257 | 10.1 | 0.44 |
| 30–39 | 1,575 | 12.6 | 0.50 |
| 40–49 | 2,200 | 17.6 | 0.65 |
| 50–59 | 2,474 | 19.8 | 0.77 |
| 60–69 | 2,108 | 16.9 | 0.80 |
| 70–79 | 1,183 | 9.5 | 0.63 |
| ≥ 80 | 271 | 2.2 | 0.23 |
| Unknown | 30 | NA | NA |
| Sex | |||
| Female | 5,118 | 40.9 | 0.43 |
| Male | 7,381 | 59.1 | 0.65 |
| Unknown | 1 | NA | NA |
| Importation status | |||
| Imported | 156 | 1.3 | NA |
| Locally-acquired | 11,507 | 98.7 | NA |
| Unknown | 837 | NA | NA |
| Hospitalisation | |||
| Yes | 7,672 | 94.9 | NA |
| No | 409 | 5.1 | NA |
| Unknown | 4,419 | NA | NA |
| Outcome | |||
| Alive | 9,594 | 97.0 | NA |
| Dead | 48 | 0.5 | NA |
| Neurological complications | 247 | 2.5 | NA |
| Unknown | 2,611 | NA | NA |
| Vaccination status | |||
| Four doses | 24 | 0.5 | NA |
| Three doses | 36 | 0.7 | NA |
| Two doses | 27 | 0.5 | |
| One dose | 33 | 0.6 | NA |
| Vaccinated unknown doses | 19 | 0.4 | NA |
| Not vaccinated | 5,066 | 97.3 | NA |
| Unknown | 7,295 | NA | NA |
NA: not available.